BFLY vs QDEL vs RTGN Stock Comparison

Butterfly Network, QuidelOrtho and RetinalGenix Technologies Prices as of Oct 28, 2026 Peers: Industry group
BFLY Butterfly Network, Inc.
$7.82 -14.5% 1M +253.8% 1Y
Market cap
$2.00B
P/E
–
Revenue (TTM)
$112.15M
Div. yield
–
Diagnostic Equipment Healthcare
5 wins
QDEL QuidelOrtho Corp
$14.01 +29.4% 1M -50.3% 1Y
Market cap
$945.61M
P/E
–
Revenue (TTM)
-$211.90M
Div. yield
–
Diagnostic Equipment Healthcare

Head to Head

6 decided of 12

Butterfly Network leads on 5 of the 12 questions below (Butterfly Network 5, RetinalGenix Technologies 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYQDELRTGNLeader
Larger companyMarket capitalisation $2.00B $945.61M $75.19M BFLY
Cheaper on earningsLower P/E, profitable companies only -26.8x -0.9x -35.9x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 18.7x — –
Faster revenue growthRevenue growth, trailing twelve months +28.1% -30.8% — BFLY
More profitableNet margin, trailing twelve months -66.7% — — –
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA — — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% — –
Better 1-year returnPrice return, last 12 months +253.8% -50.3% +6.4% BFLY
Better 5-year returnAnnualised price return, 5 years -5.4%/yr -36.2%/yr — BFLY
Less volatileAnnualised volatility, 1 year 115.0% 92.9% 25.4% RTGN
Higher overall scoreMean of the five percentile scores vs peers 45/100 22/100 36/100 BFLY

Percentile Scorecard

BFLYQDELRTGN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYQDELRTGN
Valuation 29 #161 of 227 46 #124 of 227 62 #86 of 227
Growth 67 #72 of 219 1 #217 of 219 56 #96 of 219
Profitability 33 #138 of 205 – –
Financial Health 61 #92 of 237 10 #213 of 237 0 #236 of 237
Shareholder Returns 37 #86 of 135 31 #94 of 135 26 #100 of 135
Overall 45 22 36
  • BFLY ranked among 247 companies in Medical Devices and Diagnostics
  • QDEL ranked among 247 companies in Medical Devices and Diagnostics
  • RTGN ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYQDELRTGNSPY
1 month -14.5%+29.4%0.0% +0.9%
3 months +10.3%-15.1%-0.2% +5.9%
6 months +58.9%+21.9%+24.7% +8.5%
Year to date +105.8%-50.9%+24.7% +13.3%
1 year +253.8%-50.3%+6.4% +12.4%
3 years +889.9%-77.0%-11.1% +88.1%
3 years, per year +114.8%-38.8%-3.9% +23.5%
5 years -24.2%-89.4%— +68.2%
5 years, per year -5.4%-36.2%— +11.0%
10 years —-28.0%— +263.4%
10 years, per year —-3.2%— +13.8%

Risk

MeasureBFLYQDELRTGNSPY
Volatility, 1Y 115.0%92.9%25.4% 12.7%
Downside volatility, 1Y 91.7%100.7%— 12.7%
Beta vs S&P 500, 1Y 3.012.62-0.04 1.00
Return / volatility, 1Y 2.21-0.540.25 0.98
Max drawdown, 5Y -93.4%-94.3%-92.0% -25.4%
From 52-week high -21.3%-60.4%-0.2% -0.9%
52-week high $9.94$35.38$4.00 $779.14
52-week low $1.97$9.96$3.20 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYQDELRTGN
P/E now vs peer median -27.4xmedian 28.8x -0.9xmedian 28.8x -35.9xmedian 28.8x
P/S now vs peer median 16.6xmedian 3.0x -4.5xmedian 3.0x —median 3.0x
EV/EBITDA now vs peer median -24.0xmedian 17.4x —median 17.4x —median 17.4x
P/FCF now vs peer median -66.4xmedian 25.7x -4.5xmedian 25.7x -157.3xmedian 25.7x
P/B now vs peer median 9.8xmedian 2.4x 0.5xmedian 2.4x -28.5xmedian 2.4x
PEG now vs peer median -1.01median 1.03 0.01median 1.03 -1.63median 1.03

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYQDELRTGN
Revenue $112.15M -$211.90M –
Gross profit $59.04M – –
Operating income -$79.38M – –
Net income -$74.85M -$1.05B -$2.09M
Free cash flow -$28.04M -$211.20M -$477.94K
R&D $38.10M – $238.87K
EPS (diluted) $-0.29 $-15.35 $-0.11
Cash & equivalents $124.66M $123.40M $27.23K
Total debt – $2.89B $245.00K
Shares (diluted) 262.10M 68.30M 18.81M
Enterprise value $1.45B $413.91M $75.14M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYQDELRTGN
P/E -27.4x -0.9x -35.9x
P/FCF -66.4x -4.5x -157.3x
P/Operating cash flow -77.5x -16.7x -157.3x
P/S 16.6x -4.5x –
P/B 9.8x 0.5x -28.5x
P/Tangible book 10.2x -1.1x -28.5x
EV/EBITDA -24.0x – –
EV/EBIT -21.9x – –
EV/Revenue 15.5x -17.6x –
EV/FCF -61.9x -17.6x -157.4x
EV/Operating cash flow -72.3x -65.1x -157.4x
PEG (3Y EPS CAGR) -1.01 0.01 -1.63

Growth

14 metrics
MetricBFLYQDELRTGN
Revenue growth (1Y) 28.1% -30.8% –
Revenue CAGR (3Y) 15.6% -27.0% –
Gross profit growth (1Y) 8.8% – –
Gross profit CAGR (3Y) 13.3% – –
Operating income growth (1Y) -14.8% – –
Operating income CAGR (3Y) 21.1% – –
Net income growth (1Y) -19.1% -124.8% 24.0%
Net income CAGR (3Y) 20.8% -107.7% 19.7%
EPS growth (1Y) -12.9% -122.8% 25.9%
EPS CAGR (3Y) 27.0% -106.5% 22.0%
Operating cash flow growth (1Y) 19.6% -128.5% 37.1%
Operating cash flow CAGR (3Y) 44.5% -27.1% -17.6%
Free cash flow growth (1Y) 12.2% -1,725% 37.1%
Free cash flow CAGR (3Y) 42.8% -30.1% -17.6%

Profitability

14 metrics
MetricBFLYQDELRTGN
Gross margin 52.6% – –
EBITDA margin -64.4% – –
Operating margin -70.8% – –
Pretax margin -66.7% – –
Net margin -66.7% – –
FCF margin -25.0% – –
Operating cash flow margin -21.4% 27.0% –
Return on equity -39.3% – –
Return on assets -26.3% – –
Return on invested capital – – –
Return on capital employed -35.1% – –
Asset turnover 0.4x 0.0x –
Cash conversion (OCF / net income) 0.3x 0.1x 0.2x
Stock comp / revenue 21.3% -20.9% –

Financial Health

11 metrics
MetricBFLYQDELRTGN
Debt / assets – 50.6% 152.1%
Debt / equity – 1.6x 0.0x
Net debt / EBITDA – – –
Debt / FCF – -13.7x -0.1x
Liabilities / assets 33.1% 68.9% 8,297%
Equity / assets 66.9% 31.1% -8,197%
Interest coverage -59.4x – –
Current ratio 4.1x 1.4x 0.0x
Quick ratio 2.7x 0.5x 0.0x
Cash ratio 2.1x 0.1x 0.0x
Altman Z-score 7.69 – –

Shareholder Returns

7 metrics
MetricBFLYQDELRTGN
Dividend yield – – –
Net buyback yield -0.4% -0.5% -0.8%
Shareholder yield -0.4% -0.5% -0.8%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYQDELRTGN
Forward P/E – 18.7xFY2026 –
EPS, next fiscal year $-0.10FY2026 $0.75FY2026 –
EPS growth, next FY – -64.6%FY2026 –
EPS growth, the year after – +101.3% –
Revenue, next fiscal year $114.50MFY2026 $2.67BFY2026 –
Revenue growth, next FY +17.3%FY2026 -2.0%FY2026 –
Revenue growth, the year after +26.0% +0.2% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYQDELRTGN
Held by institutions 59.9% 100.0% –
Institutions holding 245 243 –
Change in shares held, QoQ +13.9% +2.9% –
Institutions buying 143 143 –
Institutions selling 59 65 –
Buyers to sellers 2.42 2.20 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYQDELRTGN
BFLY 1.00 0.23 -0.06
QDEL 0.23 1.00 -0.01
RTGN -0.06 -0.01 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, QDEL and RTGN?

Butterfly Network (BFLY) is the largest by market capitalisation: Butterfly Network (BFLY) $2.00B, QuidelOrtho (QDEL) $945.61M, RetinalGenix Technologies (RTGN) $75.19M.

Which company is growing faster?

Butterfly Network (BFLY) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +28.1%, QuidelOrtho (QDEL) -30.8%.

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +253.8%, QuidelOrtho (QDEL) -50.3%, RetinalGenix Technologies (RTGN) +6.4%. Over five years, Butterfly Network (BFLY) compounded fastest (Butterfly Network (BFLY) -5.4%/yr, QuidelOrtho (QDEL) -36.2%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, RetinalGenix Technologies (RTGN) has been the steadiest (Butterfly Network (BFLY) 115.0%, QuidelOrtho (QDEL) 92.9%, RetinalGenix Technologies (RTGN) 25.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, QDEL and RTGN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Butterfly Network (BFLY) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.